by Market Overview:
Allogeneic stem cell transplantation involves transplanting stem cells from a donor into a patient. It is a type of stem cell therapy used to replace damaged or destroyed stem cells in conditions like cancers (leukemia, lymphoma), bone marrow failure disorders, and genetic disorders. Stem cells are extracted from bone marrow or peripheral blood of a healthy donor. These stem cells have the potential to develop into different type of blood cells in the recipient’s body. Allogeneic transplantation helps treat diseases where a patient’s bone marrow or stem cells are damaged or not working properly. It allows replacement of the stem cells with healthy donor cells. The allogeneic transplantation market includes products & services used for stem cell collection, processing, cryopreservation, and transplantation.
Market Dynamics:
Two key drivers anticipated to boost growth of the allogeneic stem cell transplantation market during the forecast period includes increasing prevalence of cancers and blood related disorders, and gradual adoption of stem cell therapy. Around 606,880 new cancer cases were reported in the United States in 2020. Blood disorders like leukemia, lymphoma affect the normal production of blood cells. Allogeneic stem cell transplantation aids in replacing the damaged stem cells of patients suffering from these conditions. Additionally, ongoing clinical research involving stem cell therapies is anticipated to uncover new avenues of application, further supporting market growth during the forecast period.
The global Allogeneic Stem Cell Transplantation Market Size is estimated to be valued at US$ 3.9 Bn in 2023 and is expected to exhibit a CAGR of 7.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Segment Analysis
The allogeneic stem cell transplantation market is segmented into stem cell source and application. The stem cell source segment is further divided into peripheral blood stem cells, bone marrow, and cord blood. Among these, the peripheral blood stem cells segment currently dominate the market due to the presence of a high number of stem cells in peripheral blood and greater success rates of transplantation.
PEST Analysis
Political: Governments of various countries are supporting stem cell transplantation through funding and favorable regulations. This is expected to boost the market growth.
Economic: Rising healthcare expenditures and increasing prevalence of blood cancer are key factors driving the economic growth of this market.
Social: Growing awareness about potential benefits of stem cell transplantation in treating diseases is supporting the social factors of the market.
Technological: Adoption of advanced technologies like automated cell processing systems, supportive care technologies is enhancing success rates of transplantation. Development of novel stem cell sources is also expected to revolutionize this market.
Key Takeaways
The global allogeneic stem cell transplantation market is expected to witness high growth, exhibiting CAGR of 7.9% over the forecast period, due to increasing prevalence of blood cancers.
Regional analysis- North America is expected to dominate the market during the forecast period owing to presence of advanced healthcare facilities and high adoption of stem cell therapy in the region. Asia Pacific is predicted to exhibit fastest growth due to rising healthcare expenditure, ever-increasing patient pool and improving research scenario in the region.
Key players- Key players operating in the allogeneic stem cell transplantation market are Celgene Corporation, Mesoblast Ltd., Pluristem Therapeutics Inc., MEDIPOST Co., Ltd., Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Cellular Biomedicine Group, Inc., Biosolution Co., Ltd., StemCell Technologies Inc., Caladrius Biosciences, Inc., TiGenix N.V., ViaCord, Vericel Corporation, Regen Biopharma Inc., Gamida Cell Ltd., Histogenics Corporation, BrainStorm Cell Therapeutics Inc., Lineage Cell Therapeutics, Inc.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemicals and materials, defense and aerospace, consumer goods, etc.
